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The Notch signaling pathway is an evolutionarily conserved intercellular signaling mechanism that is required for embryonic
development, cell fate speciﬁcation, and stem cell maintenance. Discovered and studied initially in Drosophila melanogaster,t h e
Notch pathway is conserved and functionally active throughout the animal kingdom. In this paper, we summarize the biochemical
mechanisms of Notch signaling and describe its role in regulating one particular developmental pathway, oogenesis in Drosophila.
1.Introduction
Utilized by the simplest metazoans through mammals,
Notch signaling is an evolutionarily conserved signaling
pathway that is required for embryonic development, cell
fate speciﬁcation, and stem cell maintenance [1–5]. Notch
signaling selects among preexisting cellular potentials to
specify diﬀerent cell fates and activate diﬀerent programs
through either promoting or suppressing diﬀerentiation,
proliferation, survival, and apoptosis [6, 7]. In humans,
mutations in this pathway cause inherited genetic diseases
suchas Alagille syndrome, spondylocostal dysostosis, Hadju-
Cheney syndrome, Tetralogy of Fallot, familial aortic valve
disease, and cerebral autosomal dominant arteriopathy with
subcortical infarcts and leukoencephalopathy. Dysregulation
of Notch activity also is associated with T-cell acute lym-
phatic leukemia and other cancers (e.g., pancreatic, ovarian,
colon, and brain tumors) [3, 8–13].
2.NotchReceptorsandLigands
The Notch gene was discovered by Morgan and col-
leagues, who observed that X-linked dominant mutations
in Drosophila caused irregular notches at the wing margin
[14, 15]. Later, Poulson found that the absence of Notch
activity in the embryo resulted in the overproduction of
neural tissue at the expense of epidermal tissue [16]. This
phenotype was termed neurogenic and was later shown to
be a characteristic phenotype of several other Drosophila
mutants. This deﬁned the Drosophila Notch pathway as a
cascade of neurogenic genes that control the formation of
the ﬂy nervous system [17]. However, Notch mutants also
exhibit several other defects in embryonic and adult tissues,
which indicates that this pathway is involved not only in
the development of the nervous system but also in cell fate
decisions. Today, with subsequent identiﬁcation of orthologs
for Notch in Caenorhabditis elegans and higher vertebrates
[18–20], it has been shown that the Notch pathway regulates
cellfatedecisions,aﬀectingalmostallcellsofcomplexanimal
tissues for proper ﬁnal diﬀerentiation.
One Notch receptor gene exists in Drosophila,t w oi nC.
elegans (Lin-12 and Glp-1) and four in mammals (Notch1,
Notch2, Notch3, and Notch4). The Notch gene encodes a
300kDa single-pass (Type 1) transmembrane receptor. In
mammals, the Notch receptors are expressed as propeptides
that are constitutively cleaved in the trans-Golgi network
by furinlike proteases at Site 1 (S1) [21, 22]. Cleavage
results in the extracellular/lumenal N-terminal fragment
and the transmembrane domain/intracellular domain/C-
terminal fragment. A heterodimer is formed through2 Genetics Research International
an o n c o v a l e n tC a ++-dependent interaction between these
two domains and is targeted to the plasma membrane to
form the receptor.
The Notch receptors have several conserved domains
[21].Theextracellulardomainhas29–36tandemepidermal-
growth-factor- (EGF-) like repeats, some of which are
required for ligand interaction [23]. For example, repeats
11–12 mediate productive interactions with ligand presented
by neighboring cells (trans-interactions), while repeats 24–
29mediateinhibitoryinteractionswithligandcoexpressedin
thesamecell(cis-interactions)[24].ManyoftheEGFrepeats
bind calcium, which determines the structure and aﬃnity
of Notch receptors for their ligands [25]. Following the
EGF repeats is a unique negative regulatory region (NRR),
which is composed of three cysteine-rich Lin-12/Notch
repeats (LNRs) and a heterodimerization domain (HD).
The NRR is conserved in all Notch receptors and prevents
receptor activation in the absence of ligand. The single
transmembrane domain has a stop-translocation signal that
contains three to four Arg/Lys residues. The Notch intra-
cellular domain (NICD) is comprised of the RAM (RBPJ
associationmolecule/module)domain,whichconsistsof12–
20 amino acids centered around a conserved Trp-Xaa-Pro
(WxP) motif [26]. This motif has a high binding aﬃnity to
CSL (an acronym for CBF/RBPJ in vertebrates, Suppressor of
Hairless in Drosophila,a n dLag-1 in C. elegans)[ 27]. A linker
containing a nuclear localization sequence (NLS) connects
the RAM domain to seven ankyrin repeats (ANK domain).
The ankyrin repeats are involved in protein interaction with
CSL and facilitate interaction with other proteins such as
deltex homologs and NUMB, which are important cytosolic
regulators of the Notch pathway. Both the RAM and ANK
regions of NICD are important for CSL-mediated Notch
signaling. Following the ANK domain is another NLS and an
evolutionarily divergent transactivation domain (TAD). The
C-terminus of the Notch receptors is comprised of conserved
Pro/Glu/Ser/Thr-rich motifs (PEST). These motifs regulate
proteinturnoveroftheNICD[28,29].DrosophilaNotchalso
contains a glutamine-rich OPA repeat, which is composed of
repeating units of the sequence triplet CAX where X is either
G, A, or T [21, 30].
Based on their domain composition, the ligands and
potential ligands of Notch receptors can be divided into
diﬀerent groups [21]. The canonical DSL (Delta and Serrate
from Drosophila and Lag-2 from C. elegans) ligands conduct
the majority of Notch signaling eﬀects. Like Notch receptors,
the DSL ligands are also type 1 transmembrane proteins,
although they have much smaller and less conserved intra-
cellular domains than the Notch receptors. The classical
Notch ligands all share a similar structure [21]: an N-
terminalDSLdomain,specializedtandemEGFrepeatscalled
the DOS domain (Delta and OSM-11-like proteins [31]),
EGF-like repeats, a transmembrane segment, and a short
(approximately 100–150 amino acids) cytoplasmic domain
[32]. The ligands can be divided into two families: homologs
of Drosophila Delta protein (DLLs, Delta-like 1, 3, and 4
in mammals) and homologs of Drosophila Serrate (JAGs,
J a g g e d1a n d2i nm a m m a l s )[ 6, 7]. This division is based
on the presence or absence of a cysteine-rich domain.
Speciﬁcally, the JAG ligands have the cysteine-rich region
proximal to the transmembrane segment. Compared to the
Delta-like ligands, JAG1 and JAG2 have almost twice the
number of EGF repeats, and some of these repeats contain
conserved insertions of unknown function [33]. Within the
same ligand type, the intracellular region of the Notch ligand
is well conserved through evolution. However, diﬀerent
ligand types have distinct cytoplasmic domains.
The DSL domain is characterized by the conserved
speciﬁc spacing of six cysteines and three glycines. Both the
DSL and DOS domains are involved in receptor binding,
with the DSL domain involved in both trans- and cis-
interactionswithNotchreceptors[7,34–36].Comparedwith
the activating trans-interactions, cis-interactions between
DSL ligands and Notch receptors inhibit Notch signaling
[37–40] and play an important role in a subset of Notch-
dependent developmental events [38, 39, 41].
The intracellular domain of JAG1, as well as DLL1 and
DLL4, contains a PDZ-ligand domain, which is required
for interactions with PDZ-containing, membrane-associated
proteins that play a role in the organization of cell-cell
junctions. PDZ stands for the three proteins ﬁrst discovered
to share the domain: postsynaptic density protein (PSD-
95), Drosophila discs large tumor suppressor (DLG1), and
zonula occludens-1 protein (ZO-1). Interaction with the
PDZ domain is independent of interaction with the Notch
receptor. For example, DLL-1/4 can recruit DLG1 at cell-
cell junctions, which results in tightening cell contacts and
a reduction in cell motility [42].
For noncanonical ligands, C. elegans and mammalian
DSL-only ligands (lacking DOS, including diﬀusible ligands)
may act alone or in combination with DOS coligands
[31, 43]. Noncanonical ligands lack both DSL and DOS
domains, such as the neural adhesion molecule CNTN1
(contactin1 or F3/contactin) [44], the related NB3 protein
[45], and the EGF repeat protein DNER (delta/notch-
like EGF-related receptor) [46], which may facilitate the
activation of Notch receptors by DSL ligands and/or DOS
coligands. The physiological function for these proteins in
the Notch pathway is yet to be established.
3. Mechanismsof CanonicalNotch Signaling
The core mechanism of canonical Notch signaling is the
release of NICD as a transcriptional regulator from the
membrane (Figure 1). This process is activated by ligand-
receptor interactions, and is controlled at many diﬀerent
levels (reviewed in [6, 21]). Activation of the canonical
Notch signaling pathway is mediated by regulated sequen-
tial proteolysis. In mammals, the Notch protein is gly-
cosylated by POFUT1 (protein O-fucosyltransferase 1) to
produce a functional receptor. After proteolytic cleavage by
PC5/6/FURIN (paired basic amino acid cleaving enzyme) at
site S1, Notch receptors are targeted to the cell surface as a
heterodimer. The O-fucose is extended by the glycosyltrans-
feraseactivityofFRINGEproteins(O-fucosylpeptide3-beta-
N-acetylglucosaminyltransferase, including lunatic, manic,
and radical fringe in mammals), which regulate the ability ofGenetics Research International 3
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Figure 1: Core components of the canonical Notch signaling pathway in Drosophila. The two Notch ligands encoded by the Serrate (Ser)
and Delta (Dl) genes (upper cell) interact with an adjacent cell expressing the Notch receptor. The Notch receptor is proteolytically cleaved
by a Furin protease in the Golgi and exists at the cell surface as a proteolytically cleaved heterodimer consisting of a large ectodomain
and a membrane-tethered intracellular domain. The receptor/ligand interaction induces additional proteolytic cleavages by ADAM-family
metalloproteasesandthegamma-secretasecomplexinthemembrane-tetheredintracellulardomain.Theﬁnalcleavage,catalyzedbygamma-
secretase, frees the Notch intracellular domain (NICD) from the cell membrane. NICD translocates to the nucleus, where it forms a complex
withtheSupressorofHairless(Su(H))protein,displacingahistonedeacetylase(HDAc)/corepressor(CoR)complexfromtheSu(H)protein.
Components of an activation complex such as the Mastermind (MAM) protein and histone acetyltransferases (HAc) are recruited to the
NICD/Su(H) complex, leading to the transcriptional activation of Notch target genes.
speciﬁc ligands to activate Notch receptors. The interaction
withligandsleadstocleavageofNotchreceptorsbyADAM(a
disintegrin and metallopeptidase domain) metalloproteases
(ADAM10/Kuzbanian and ADAM17/TACE) at site S2, which
is located about twelve amino acids before the transmem-
brane domain. In the absence of ligand, the S2 cleavage site
is in a β-strand, deeply buried within the NRR [47]. After
ligand binding, the Notch ectodomain is transendocytosed
by ligand-presenting/signal-sending cells while the NICD
is localized in signal-receiving cells [48]. Transendocytosis
generates suﬃcient force to promote a conformational
change that exposes S2 site for cleavage, which results in the
generation of membrane bound intracellular Notch peptides
(NEXT, for Notch extracellular truncation) [49, 50].
NEXT is a substrate for cleavage by the γ-secretase com-
plex, composed of presenilin 1 and 2 as well as nicastrin and
alphaprotein 1 [51]. γ-secretase cleaves NEXT progressively,
starting at the S3 site near the inner leaﬂet and ending at the
S4 site near the middle of the transmembrane domain. γ-
secretase cleavage can occur at the cell surface or in endo-
somal compartments; however, cleavage at the membrane
results in the more stable form of NICD. This processing
event releases NICD, which constitutively translocates into
the nucleus, where it interacts via its RAM domain with
the primary nuclear eﬀecter of Notch signaling, the DNA-
binding protein CSL.
The mammalian homologue of CSL is called C promoter
binding factor 1 (CBF1) or recombination signal binding
protein for immunoglobulin kappa J region (RBPJ), which
mediates canonical Notch signaling [52]. The constitutively
expressed RBPJ binds to a speciﬁc sequence on promot-
ers of Notch target genes and regulates their expression.
In the absence of NICD, RBPJ associates with ubiqui-
tous corepressor (Co-R) proteins and histone deacetylases
(HDACs), thereby repressing the transcription of speciﬁc
target genes. Molecular and phenotypic experiments have
shown that CBF1 can interact with various corepres-
sors, including NCoR/SMRT (nuclear receptor corepressor
2), MINT/SHARP/SPEN (SPEN homolog, transcriptional
regulator), CIR1 (corepressor interacting with RBPJ-1),
and Groucho/transducin-like enhancer complexes [21, 53].
Diﬀerent RBPJ-associated repressor complex components
assemble on diﬀerent Notch target promoters, with varia-
tions in the arrangement of RBPJ binding sites and tran-
scriptional repressor complex types, resulting in regulation
of gene expression (reviewed in [54]).
Upon ligand-induced Notch activation, the released
NICD translocates into the nucleus and binds to RBPJ,
which is crucial for the switch from a repressed to an
activated state. NICD ﬁrst displaces corepressors from RBPJ
to derepress promoters containing RBPJ binding sites.
Subsequently associating with RBPJ, the ANK domain of4 Genetics Research International
NICD recruits the transcriptional coactivator mastermind
like proteins (Maml1-3) to form an RBPJ/NICD/MAML
ternary complex. Conformational changes among the RBPJ,
NICD,andMAMLproteinsdrivethefoldingofunstructured
proteinsegmentsandfacilitatebindingofotherspeciﬁccoac-
tivators to form an activator complex. General transcription
factors are recruited, such as the histone acetyltransferase
p300, the coregulator SKIP (Ski-interacting protein), the
CDK8-mediator complex, and other mediator complexes,
leading to the acetylation of chromatin and upregulation of
downstream target genes (reviewed in [55, 56]).
Among various downstream target genes, the major
targets of Notch signaling are the hairy/enhancer of split
(Hes) and the Hes-related (Hesr/Hey)f a m i l yo fb a s i ch e l i x -
loop-helix (bHLH) transcription factors [57, 58]. These are
highly conserved proteins that function as transcriptional
repressors. In mammals, well-described Notch target genes
include the transcription factors Hes1, Hes5, and Hey1
[59]. Hes1 knockout mice are not viable and have multiple
developmental defects [57]. Hes1 and Hes5 overexpression in
bone marrow partly inhibits B-cell development [60]. Il2ra
(CD25, IL2-R alpha chain) and Ptcra (pre-T-cell receptor
alpha chain) are Notch target genes in T cells [61, 62].
Transcription factor Gata3 is also a direct Notch target gene
as a master regulator for T-cell development and later for
the Th1/2 lineage decision [63]. Nrarp (Notch-regulated
ankyrin repeat protein) and Deltex-1 are two Notch target
genes shown as potent negative regulators of Notch signaling
[64, 65]. Furthermore, Myc (c-myc), Ccnd1 (cyclin D1),
and Cdkn1a (p21/Waf1) are Notch target genes implicated
in cancer. Other Notch target genes include Nfkb2, Iﬁ202a,
Iﬁ204, Iﬁ205 (D3), Adam19, Notch1, Notch3, Bcl2, Tcf3
(E2A), and Hoxa5, 9, and 10 (reviewed in [53]).
4.Drosophila Oogenesis
Drosophila oogenesis as a model system has been used to
investigate many aspects of developmental and cell biology.
The development of a mature egg from a single stem
cell requires almost every cellular process: from cell fate
speciﬁcation, cell cycle control, and cell polarization to
epithelial morphogenesis. The Drosophila o v a r yi sm a d eu p
o fa b o u t1 6t o2 0o v a r i o l e s ,e a c ho fw h i c hr e p r e s e n t sa n
egg production line. Each oocyte develops within a group
of cells called an egg chamber (or follicle), which consists of
a cluster (or cyst) of 16 germ cells surrounded by somatic
follicle cells [66]. At the anterior end of the ovariole is
the germarium, which contains somatic and germline stem
cells. The germarium is divided into four regions based
on morphological diﬀerences: regions 1, 2a, 2b, and 3. Egg
chambers leave the germarium and mature as they move
posteriorly in the ovariole. An ovariole usually contains six
to seven sequentially more mature follicles, separated by
interfollicular stalk cells. Oogenesis has been divided into 14
stages based on morphological criteria. Stage one is forming
of the egg chamber from the germarium, and stage 14 is an
egg chamber with a mature egg [67].
The germarium is where new egg chambers are gen-
erated. The two germ-line stem cells (GSCs) are located
at the anterior end, close to their niche composed of cap
cells and terminal ﬁlament [68]. The niche prevents GSC
diﬀerentiation and promotes their self-renewal. The two
GSCs alternate in producing one cystoblast at a time. They
divide asymmetrically to produce another stem cell and a
daughtercell,whichbeginstodiﬀerentiate.Afterfourmitotic
divisions with incomplete cytokinesis, the daughter cells
form a cyst of 16 cells interconnected by cytoplasmic bridges
known as ring canals. Each cyst contains eight cells with one
ring canal, four with two, two with three, and two with four
ring canals. One of the initial two cells with four ring canals,
which are called pro-oocytes, will become the oocyte, while
all the others become nurse cells. The nurse cells provide
nutrientsandcytoplasmiccomponentstotheoocytethrough
the ring canals. Within the cyst the oocyte is the only cell
that progresses to meiosis. Before exiting the germarium the
oocyte arrests in meiotic prophase I, and meiosis does not
continue until the mature egg is laid and activated.
The process of oocyte determination occurs gradually
as the cyst proceeds through the germarium (reviewed in
[69]). Germ cells have a cytoplasmic structure called the
spectrosome, which is spherical and contains components of
the submembrane cytoskeleton. At the ﬁrst mitotic division,
the spectrosome goes to only one of the two daughter cells.
During the following divisions, a branched structure called
the fusome is formed when the spectrosome grows from this
cellinto theothercells[69]. When thecystoblastdivides, one
pole of the spindle is anchored by the inherited spectrosome
(the original fusome), while a new fusome plug forms in
the ring canal, at the opposite pole of the cell. The two
fusomes then come together to fuse, so that one cell contains
the original fusome plus half of the new one, whereas the
other cell only retains the other half of the fusome plug.
This asymmetric patterning of the fusome is then repeated
until the cells ﬁnish the fourth division. Therefore the
original fusome and more fusome plugs are retained in the
oldest cell, in which the fusome always marks the anterior
of the cell. This movement of the fusome minimizes the
distance between the ring canals. Later on the formation
of adherens junctions around the ring canals will stabilize
the shape. Most of the fusomes will degenerate by the time
oocyte-speciﬁc proteins such as BicD (Bicaudal D) or Orb
(oo18 RNA-binding protein) accumulated in a single cell in
late region 2a. There is a preferential accumulation of the
c e n t r o s o m e sa sw e l la so fosk (oskar) and orb mRNAs in this
cell with the most fusomes, although it does not rule out the
possibility that the other pro-oocyte can become the oocyte
too.
As the cysts move through the posterior region of the
germarium, they interact with follicle cells. Cysts in the
anterior portion of this part of the germarium, known
as region 2a, have not been fully enclosed by the follicle
cells and still directly contact neighboring cysts [67]. When
the cyst gets to region 2b, it changes to a one cell-
layer disc and spans the whole width of the germarium,
with oocyte-speciﬁc factors concentrated in the oocyte and
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a polarized microtubule network that is polarized toward the
oocyte and extends into all 16 cells through the ring canals.
The somatic or follicle stem cells locate at the junction of
regions 2a and 2b and give rise to precursor follicle cells.
Sixteenoftheprecursorfolliclecellsinvadebetweenthecysts,
cease division, and develop into polar cells and stalk cells,
which play a critical role in follicle formation. The rest of
the precursor cells form an epithelial layer around the cyst,
producing an egg chamber. The newly formed four to six
stalk cells separate the egg chamber from the germarium.
By the time the somatic follicle cells surround the
cyst, cell fate markers and markers of meiotic chromosome
pairing are restricted to the oocyte, which localizes at the
posterior of the egg chambers. As the cyst moves down
to region 3 in the germarium (stage 1), a structure called
the Balbiani body, which consists of the fusome remnant,
mitochondria, centrosomes, a Golgi vesicle, proteins, and
mRNAs, is formed at the anterior of the oocyte. At the same
time, the cyst rounds up with the oocyte always lying on
the posterior edge. As all of the components of the Balbiani
body disassociate and move to the posterior cortex, the
polarization of the oocyte is established.
When a newly formed egg chamber buds from the ger-
marium, it enters the larger, more posterior region of
the ovariole, the vitellarium, consisting of six to seven
progressively older follicles. A series of cell-cell signaling
events between the germline and the soma and between
diﬀerent populations of somatic cells control the formation
of a discrete, correctly polarized and patterned egg chamber.
Many signaling pathways play important roles during the
course of egg chamber development. Correctly deﬁned and
maintained polarity in the oocyte is critical, since this will
determine the body axis of the embryo. At the same time,
the correctly patterned somatic follicle cells form an intact
eggshell and other extraembryonic structures, such as the
dorsal appendages.
The establishment of the ﬁnal anterior-posterior polarity
in the oocyte is a two-step process. First, in the germarium
gurken mRNA, which is part of the Balbiani body, localizes
at the posterior of the oocyte as the oocyte polarizes and
locates in the posterior end in region 3 [69]. Gurken protein
signals to the adjacent follicle cells and results in the adjacent
terminal follicle cells developing to a posterior rather than
an anterior fate. These posterior follicle cells then induce a
repolarisation of the microtubule cytoskeleton in the oocyte
at stage 7, which transports the bicoid mRNA to the anterior
of the oocyte and oskar mRNA to the posterior. By stage
9, the microtubule plus ends accumulate in a compartment
at the posterior cortex of the oocyte, with the minus ends
predominantly at the anterior region of the oocyte and some
extending along the lateral cortex. This microtubule polarity
within the oocyte will direct the localization of the RNAs and
associated proteins, which deﬁne the anterior-posterior axis.
Follicle cells proliferate during stages 1–6 of oogenesis.
The egg chamber enlarges during stages 7–9 of oogenesis.
The oocyte in the follicle grows signiﬁcantly, uptakes yolk
protein synthesized in the follicle cells, and occupies almost
half the egg chamber by stage 10A. Follicle cells cease their
mitosis after stage 6 and stay as a cuboidal epithelium
through stage 8. The ﬁrst step of follicular epithelium
diﬀerentiation is the speciﬁcation of the terminal follicular
cells versus the main body follicular cells. The terminal cells
at the anterior pole give rise to the border cells, the stretched
cells, and the centripetal cells [70]. These three populations
cannot be recognized before stage 9 or 10, when speciﬁc
genes and proteins are expressed and several morphogenetic
features become obvious. In stage 9, reorganization begins
through a series of migrations. The majority of the follicle
cells stay as a columnar epithelium over the oocyte, leaving
around 50 follicle cells as a squamous epithelium over the
nurse cells. The 6 to 10 anterior-tip follicle cells become
the border cells. They delaminate from the epithelial follicle
cells, extend protrusions in between the nurse cells, migrate
approximately 100μm to the border between the nurse cells
and the oocyte, and cover the anterior end of the oocyte.
During stages 10B to 14, nurse cells contribute maternal
mRNAs and proteins to the oocyte by a cytoskeleton-based
mechanism and transfer their cytoplasm into the oocyte
to help it reach its large size. The follicle cells synthesize
the vitelline membrane, then the eggshell over the oocyte.
After the completion of the eggshell and the dumping of the
nurse cell cytoplasm, the follicle cells and nurse cells undergo
apoptosis, leaving behind the mature egg. Specialized follicle
cells also make the micropyle for sperm entry. The anterior
end of a mature egg also has a pair of dorsal appendages for
embryonic respiration and an operculum for larval exit [71].
5. Notch Signalingduring
Drosophila Oogenesis
Work by many investigators has shown that Delta-Notch
signaling is required for numerous important aspects of
oogenesis in Drosophila melanogaster. Many of these func-
tions have been studied genetically using mutant alleles of
Notch, Delta, and Serrate and by ectopic expression of Delta
or constitutively activated forms of the Notch receptor.
5.1. Germline Stem Cell Niche Formation. GSC niche for-
mation and maintenance require Notch signaling. Delta
and Serrate on the surface of GSCs activate Notch in the
somatic cells to form and maintain the GSC niche, and the
niche induces and maintains stem cell fate in return [72].
Ectopic or expanded activation of Notch signaling leads to
the formation of more cap cells and larger niches, which
in turn induce ectopic or more GSCs; conversely, decreased
Notch signaling during niche formation results in reduced
capcellnumberandnichesize,andconsequentlyfewerGSCs
[73].
5.2. Specifying Polar Cells and Stalk Cells. Notch signaling
regulates multiple aspects of the diﬀerentiation of somatic
follicle cells in the Drosophila ovary (reviewed in [74]),
including diﬀerentiation of the stalk and polar cells [75].
This function also involves fringe (fng) ,aN o t c hp a t h w a y
modulator, which is expressed in the polar/stalk precursors
and makes them competent to react to the Delta signal [76].
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results in huge fused egg chambers without polar cells. Loss
of fng also results in egg chambers without polar cells [77,
78]. Loss of Delta in the follicle cells results in encapsulation
of the cysts by the follicle cells, but stalk formation does not
occur. Expression of constitutively active Notch results in
more polar cells and long stalks between the egg chambers.
The formation of polar and stalk cell fates depends on
diﬀerent levels of Notch activation. The future polar cells
have high-level Notch activation, resulting from a germline
Delta signal. Stalk cells show low-level Notch activation,
which comes from a Delta signal in the polar cells. In polar
cells, the metalloprotease Kuzbanian-like (Kul) cleaves and
inactivates Delta, reducing the level of Delta signaling so
that the stalk precursors next to them can be induced into
stalk cells [79]. A recent study has shown that Delta-Notch
signaling is required for lateral migration of follicle stem cell
daughters across the ovariole as well as for follicle stem cell
replacement [80].
5.3. Establishment of Anterior-Posterior Polarity. The forma-
tion of the polar and stalk cells occurs by a relay mechanism,
which also helps to establish the anterior-posterior axis of
Drosophila [81]. When a germline cyst reaches region 3 of
the germarium, its oocyte has already been positioned to
the posterior. Polar/stalk precursors separate the cyst from
the adjacent younger cyst in region 2b. Delta signals from
the germline cyst activate Notch in the adjacent anterior
polar/stalk precursors, inducing them to form polar cells
[82]. The more anterior polar/stalk precursors diﬀerentiate
as stalk cells after receiving a Delta signal from these anterior
polar cells. The stalk cells interact with each other and come
together toward the middle to form a two cell-wide stalk.
This movement forces the younger anterior cyst to round
up, being pulled into region 3. At the same time, the stalk
induces increased expression of DE-cadherin in the follicle
cells that contact the oocyte in the younger cyst, resulting in
a preferential adherence between these cells and the oocyte
andaposteriorpositionoftheoocyte.Whentheyoungercyst
ﬁnishes all these events, it is in region 3 of the germarium
and Delta signaling is activated, which then induces polar
cell fate in the polar/stalk precursors in its anterior, and the
cycle starts again. During stages 5 to 7, Delta signaling from
the germ cells is required for the establishment of anterior-
posterior polarity and diﬀerentiation of the epithelial follicle
cells. Notch mutant epithelial follicle cells at these stages fail
to express diﬀerentiation markers, resulting in the follicle
cells being unable to respond to Gurken by turning on
posteriordiﬀerentiationmarkers.Sowithoutthemodulation
of Notch signaling, the posterior follicle cells cannot be
formed and the anterior-posterior axis of the oocyte is not
established [76, 79].
5.4. Mitotic Cycle to Endocycle Switch and Diﬀerentiation
of Epithelial Follicle Cells. At the end of stage 6, epithelial
f o l l i c l ec e l l ss w i t c hf r o mam i t o t i cc e l lc y c l et oam o d i ﬁ e d
cell cycle, called the endocycle, where DNA is duplicated
withoutcelldivision(endoreplication).Deltainthegermline
and Notch in the follicle cells are required for this switch
[82, 83]. After switching to endoreplicative cycles, follicle
cells diﬀerentiate by responding to subsequent inductive
signals. Notch is required in all epithelial follicle cells for
this switch from immature to diﬀerentiated follicle cells.
Increased Delta expression in the germline at stage 6 is
responsibleforactivationofNotchinthesurroundingfollicle
cells, causing them to switch from mitosis to endoreplication
cycles. Follicles mutant for Notch at stage 10 display defects
in the diﬀerentiation of the border, stretched, and centripetal
cells, and abnormal migration. At stage 9, Fng-dependent
Notch activity is required in the stretched cells and in the
most anterior main body follicle cells. Stretched cells require
Notch activation to disassemble their adherens junctions
for ﬂattening of the stretched cells. Inactivation of Notch
signaling in anterior follicle cells, by lack of Fng either
alone, or both Dl and Ser, results in clusters of main body
follicle cells remaining over the nurse cells [70, 82, 84]. The
transcriptional cofactor corepressor for element-1-silencing
transcription factor (CoREST) is a newly discovered positive
modulator of Notch signaling in somatic follicle cells [85].
Loss of CoREST function in follicle cells disrupted the
mitotic-to-endocycle switch at stage 6 of oogenesis. CoREST
positively regulates Notch signaling, acting downstream
of the proteolytic cleavage of Notch. Subsequent to the
mitotic to endocycle switch, main body follicle cells begin
synchronized ampliﬁcation of the chorion genes, which has
been termed the endocycle to gene ampliﬁcation switch. A
recent study demonstrates that downregulation of Notch
signaling activity plus activation of the ecdysone receptor,
acting through the zinc ﬁnger protein Tramtrack, is required
for the endocycle to gene ampliﬁcation switch [86].
5.5.MigrationofBorderCells. TheNotchpathwayisrequired
for normal border cell migration and is activated in border
cells during their migration. Unlike the widespread activa-
tionofNotchinfolliclecellsatstage6,Notchisonlyactivated
inthebordercellsatstage9.ExpressionofKuzbanian(KUZ),
a metalloproteinase that can activate Notch and cleave other
substrates, is highly expressed in border cells at the same
time [87]. Conditional knockout and/or dominant-negative
alleles of KUZ, Notch, and Delta all demonstrate abnormal
border cell migration. A dominant-negative form of Kuz
decreases Notch activity and inhibits border cell migration
without aﬀecting expression of markers of border cell fate
or follicle cell diﬀerentiation. The ability of the cells to
detach from the follicular epithelium is signiﬁcantly reduced
without aﬀecting direction sensing [87, 88].
5.6. Centripetal Migration. By stage 10B high levels of Notch
protein accumulate in the centripetal migrating cells, which
close oﬀ the anterior end of the oocyte while synthesizing the
operculum and micropyle. Centripetal migration is blocked
in a Notch mutant [84]. The expression of the bunched (bun)
gene in the anterior centripetal follicle cells is repressed. In
nearby cells, bun antagonizes Notch signaling to prevent the
posterior cells from diﬀerentiating into centripetal follicle
cell fates, including gene expression, cell shape changes,
and accumulation of cytoskeletal components. bun represses
Serrate and Delta expression in posterior follicle cells,Genetics Research International 7
coinciding with a boundary of Notch activation in the
centripetal follicle cells. Another gene, slow border cells
(slbo), is expressed in centripetally migrating cells as well.
At stage 10A, slbo expression overlaps bun expression in
anterior follicle cells; by stage 10B they repress each other’s
expression to establish a sharp slbo/bun expression boundary
between migrating and nonmigrating cells. As centripetal
migration proceeds from stages 10B to 14, slbo represses
its own expression and both slbo loss-of-function and
overexpression mutations reveal that slbo is required for
centripetal migration. Interactions among Notch, slbo, and
bun regulate centripetal migration. The precise position
of the slbo/bun expression boundary is sensitive to Notch
signaling, which is required for both slbo activation and
bun repression [71, 89]. Increased Notch signaling leads to
increased slbo expression both in the centripetal follicle cells
and in adjacent columnar follicle cells. Dynamic interactions
among Bun, Slbo, and Notch signaling tightly regulate DE-
cadherinlevelsinthecentripetalfolliclecells.AbsenceofDE-
cadherin in the germline results in migration of follicle cells
between the nurse cells. Migration also is disrupted when
follicle cells without DE-cadherin expression are in or near
the centripetally migrating follicle cells [71, 84, 89, 90].
5.7.DorsalAppendageFormation. Duringstages9–10,dorsal
appendage-forming cells are speciﬁed by a combination
of the BMP, EGF, and Notch pathways [71, 91]. By stage
11, these epithelial cells can be found at the dorsoanterior
corner of the egg chambers. They constrict apically and
move inside-out, turning from a ﬂat layer into tubular
structures. The appendages are formed after the secretion
of chorionic proteins into the tube lumens. Notch signaling
plays an important role in establishing a boundary between
the Rhomboid- and the Broad-positive cells, which form the
dorsal and ventral portions of the dorsal appendage tube. A
diﬀerence in Notch levels in adjacent cells is critical for this
process. At the boundary, cells with high Notch levels express
Rhomboid,w h e r e a sc e l l sw i t hl o w e rN o t c he x p r e s sBroad.
When Notch is absent in cells that span the boundary, Rhom-
boid is not expressed, and Broad is ectopically expressed.
Therefore Notch signaling regulates the patterning of both
Rhomboid-a n dBroad-positive cell types at the boundary.
The establishment of this border is important for preventing
intermingling of these cell types during tube formation [71,
92]. In a similar manner to their cooperation during the
endocycle to gene ampliﬁcation switch [86], the Tramtrack
transcription factor, Notch signaling, and ecdysone receptor
activation cooperate to control the volume of the dorsal
appendagetubesbypromotingapicalreexpansionandlateral
shortening of dorsal appendage-forming follicle cells [93].
6.Perspectives
The studies described in the preceding section clearly
demonstrate the multiple important roles played by the
Notch signaling pathway during Drosophila oogenesis. An
unanswered question, however, is whether a critical role for
Notch signaling during oogenesis exists in other organisms,
such as mammals. In situ hybridization analyses of adult
mouse ovaries demonstrated that the Notch2, Notch3, and
Jag2 genes are expressed in granulosa cells (the somatic
cells of the ovarian follicle), and the Jag1 gene is expressed
in the oocytes [94]. Furthermore, the Notch target genes
Hey1 and Hey2 are also expressed in the somatic follicle
cells. A similar pattern of expression was observed during
the early neonatal period, when ovarian primordial follicles
are assembled [95]. Culture of neonatal mouse ovaries in
γ-secretase inhibitors led to defects in the early stages of
follicle development [95, 96]. These data indicate that Notch
signal reception is occurring in the somatic follicle cells of
the mouse ovary and are consistent with the model that
Notch signal reception in granulosa cells is essential for
ovarianfollicledevelopment.However,γ-secretaseinhibitors
have many substrates in addition to Notch family receptors
[97]. Genetic analyses, such as oocyte- and granulosa cell-
speciﬁc deletion of Notch ligands and receptors in mutant
mice, will be required to conﬁrm a role for Notch signaling
duringmammalianoogenesisandtodeterminewhichNotch
pathway components are essential for this process.
Acknowledgments
This review was prepared in partial fulﬁllment of the
requirements for the degree of Doctor of Philosophy from
the University of Maine (J. Xu). Work on the Notch signaling
pathway in T.G.’s laboratory was supported by the NIH
(Grant R01HD034883).
References
[1] S. Artavanis-Tsakonas, M. D. Rand, and R. J. Lake, “Notch
signaling: cell fate control and signal integration in develop-
ment,” Science, vol. 284, no. 5415, pp. 770–776, 1999.
[2] A. Penton, L. Leonard, and N. Spinner, “Notch signaling in
human development and disease,” Seminars in Cell & Devel-
opmental Biology. In press.
[3] P. Ranganathan, K. L. Weaver, and A. J. Capobianco, “Notch
signalling in solid tumours: a little bit of everything but not all
the time,” Nature Reviews Cancer, vol. 11, no. 5, pp. 338–351,
2011.
[4] A. Apelqvist, H. Li, L. Sommer et al., “Notch signalling con-
trolspancreaticcelldiﬀerentiation,”Nature,vol.400,no.6747,
pp. 877–881, 1999.
[5] X. Zhu, J. Zhang, J. Tollkuhn et al., “Sustained Notch signaling
in progenitors is required for sequential emergence of distinct
cell lineages during organogenesis,” Genes and Development,
vol. 20, no. 19, pp. 2739–2753, 2006.
[6] S. J. Bray, “Notch signalling: a simple pathway becomes com-
plex,” Nature Reviews Molecular Cell Biology, vol. 7, no. 9, pp.
678–689, 2006.
[7] U. M. Fiuza and A. M. Arias, “Cell and molecular biology of
Notch,” Journal of Endocrinology, vol. 194, pp. 459–474, 2007.
[8] F. Jundt, R. Schwarzer, and B. D¨ orken, “Notch signaling in
leukemias and lymphomas,” Current Molecular Medicine, vol.
8, no. 1, pp. 51–59, 2008.
[9] P. Mysliwiec and M. J. Boucher, “Targeting Notch signaling
in pancreatic cancer patients—rationale for new therapy,”
Advances in Medical Sciences, vol. 54, no. 2, pp. 136–142, 2009.8 Genetics Research International
[10] S. L. Rose, “Notch signaling pathway in ovarian cancer,”
InternationalJournalofGynecologicalCancer,v ol.19,no .4,pp .
564–566, 2009.
[11] J. H. Van Es, M. E. Van Gijn, O. Riccio et al., “Notch/γ-
secretase inhibition turns proliferative cells in intestinal crypts
andadenomasintogobletcells,”Nature,vol.435,no.7044,pp.
959–963, 2005.
[12] T. J. Pierfelice, K. C. Schreck, C. G. Eberhart, and N. Gaiano,
“Notch, neural stem cells, and brain tumors,” Cold Spring
HarborSymposiaonQuantitativeBiology,vol.73,pp.367–375,
2008.
[13] V. Garg, A. N. Muth, J. F. Ransom et al., “Mutations in
NOTCH1 cause aortic valve disease,” Nature, vol. 437, no.
7056, pp. 270–274, 2005.
[14] O. L. Mohr, “Character changes caused by mutation of an
entire region of a chromosome in Drosophila,” Genetics, vol.
4, pp. 275–282, 1919.
[15] T. H. Morgan, “Sex limited inheritance in drosophila,”Science,
vol. 32, no. 812, pp. 120–122, 1910.
[16] D. F. Poulson, “Chromosomal deﬁciencies and the embryonic
development of Drosophila melanogaster,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 23, pp. 133–137, 1937.
[17] H. Vassin, J. Vielmetter, and J. A. Campos-Ortega, “Genetic
interactions in early neurogenesis of Drosophila melanogaster,”
Journal of Neurogenetics, vol. 2, no. 5, pp. 291–308, 1985.
[18] K. A. Wharton, K. M. Johansen, T. Xu, and S. Artavanis-
Tsakonas, “Nucleotide sequence from the neurogenic locus
Notch implies a gene product that shares homology with
proteins containing EGF-like repeats,” Cell,v o l .4 3 ,n o .3 ,p p .
567–581, 1985.
[19] J. Yochem, K. Weston, and I. Greenwald, “The Caenorhabditis
elegans lin-12 gene encodes a transmembrane protein with
overall similarity to Drosophila Notch,” Nature, vol. 335, no.
6190, pp. 547–550, 1988.
[20] G. Weinmaster, V. J. Roberts, and G. Lemke, “A homolog
of Drosophila Notch expressed during mammalian develop-
ment,” Development, vol. 113, no. 1, pp. 199–205, 1991.
[21] R. Kopan and M. X. G. Ilagan, “The canonical notch signaling
pathway: unfolding the activation mechanism,” Cell, vol. 137,
no. 2, pp. 216–233, 2009.
[22] F. Logeat, C. Bessia, C. Brou et al., “The Notch1 receptor is
cleaved constitutively by a furin-like convertase,” Proceedings
of the National Academy of Sciences of the United States of
America, vol. 95, no. 14, pp. 8108–8112, 1998.
[23] I. Rebay, R. J. Fleming, R. G. Fehon, L. Cherbas, P. Cherbas,
and S. Artavanis-Tsakonas, “Speciﬁc EGF repeats of Notch
mediate interactions with Delta and Serrate: implications for
Notch as a multifunctional receptor,” Cell,v o l .6 7 ,n o .4 ,p p .
687–699, 1991.
[24] J. F. De Celis and S. J. Bray, “The Abruptex domain of Notch
regulates negative interactions between Notch, its ligands and
Fringe,” Development, vol. 127, no. 6, pp. 1291–1302, 2000.
[25] J. Cordle, C. Redﬁeld, M. Stacey et al., “Localization of the
delta-like-1-binding site in human Notch-1 and its modula-
tion by calcium aﬃnity,” Journal of Biological Chemistry, vol.
283, no. 17, pp. 11785–11793, 2008.
[26] O. Y. Lubman, M. X. G. Ilagan, R. Kopan, and D. Barrick,
“Quantitative dissectionof thenotch:CSL interaction: insights
into the notch-mediated transcriptional switch,” Journal of
Molecular Biology, vol. 365, no. 3, pp. 577–589, 2007.
[27] S. Tani, H. Kurooka, T. Aoki, N. Hashimoto, and T. Honjo,
“The N- and C-terminal regions of RBP-J interact with the
ankyrin repeats of Notch1 RAMIC to activate transcription,”
Nucleic Acids Research, vol. 29, no. 6, pp. 1373–1380, 2001.
[28] R. Kopan, J. S. Nye, and H. Weintraub, “The intracellular
domain of mouse Notch: a constitutively activated repressor
of myogenesis directed at the basic helix-loop-helix region of
MyoD,” Development, vol. 120, no. 9, pp. 2385–2396, 1994.
[29] I. Greenwald, “Structure/function studies of lin-12/Notch
proteins,” Current Opinion in Genetics and Development, vol.
4, no. 4, pp. 556–562, 1994.
[30] K. A. Wharton, B. Yedvobnick, V. G. Finnerty, and S.
Artavanis-Tsakonas, “opa: a novel family of transcribed
repeats shared by the Notch locus and other developmentally
regulated loci in D. melanogaster,” Cell, vol. 40, no. 1, pp. 55–
62, 1985.
[31] H. Komatsu, M. Y. Chao, J. Larkins-Ford et al., “OSM-
11 facilitates LIN-12 Notch signaling during Caenorhabditis
elegans vulval development,” PLoS Biology, vol. 6, no. 8, article
e196, 2008.
[32] I. Letunic, R. R. Copley, B. Pils, S. Pinkert, J. Schultz, and
P. Bork, “SMART 5: domains in the context of genomes and
networks,” Nucleic acids research., vol. 34, pp. D257–D260,
2006.
[33] G. Weinmaster, “The ins and outs of Notch signaling,”
Molecular and Cellular Neurosciences, vol. 9, no. 2, pp. 91–102,
1997.
[34] A.L.Parks,J.R.Stout,S.B.Shepardetal.,“Structure-function
analysis of delta traﬃcking, receptor binding and signaling in
Drosophila,” Genetics, vol. 174, no. 4, pp. 1947–1961, 2006.
[35] K. Shimizu, S. Chiba, K. Kumano et al., “Mouse Jagged1
physically interacts with Notch2 and other Notch receptors.
Assessment by quantitative methods,” Journal of Biological
Chemistry, vol. 274, no. 46, pp. 32961–32969, 1999.
[36] A. Zolkiewska, “ADAM proteases: ligand processing and
modulation of the Notch pathway,” Cellularand MolecularLife
Sciences, vol. 65, no. 13, pp. 2056–2068, 2008.
[37] M. Glittenberg, C. Pitsouli, C. Garvey, C. Delidakis, and
S. Bray, “Role of conserved intracellular motifs in Serrate
signalling,cis-inhibitionandendocytosis,”EMBOJournal,vol.
25, no. 20, pp. 4697–4706, 2006.
[38] T. L. Jacobsen, K. Brennan, A. M. Arias, and M. A. T. Muskav-
itch, “Cis-interactions between Delta and Notch modulate
neurogenic signalling in Drosophila,” Development, vol. 125,
no. 22, pp. 4531–4540, 1998.
[39] T. Klein and A. Martinez Arias, “Interactions among Delta,
SerrateandFringemodulateNotchactivityduringDrosophila
wing development,” Development, vol. 125, no. 15, pp. 2951–
2962, 1998.
[40] E. Ladi, J. T. Nichols, W. Ge et al., “The divergent DSL ligand
Dll3 does not activate Notch signaling but cell autonomously
attenuates signaling induced by other DSL ligands,” Journal of
Cell Biology, vol. 170, no. 6, pp. 983–992, 2005.
[41] J. F. De Celis and S. Bray, “Feed-back mechanisms aﬀect-
ing Notch activation at the dorsoventral boundary in the
Drosophila wing,” Development, vol. 124, no. 17, pp. 3241–
3251, 1997.
[42] E. M. Six, D. Ndiaye, G. Sauer et al., “The Notch ligand Delta1
recruits Dlg1 at cell-cell contacts and regulates cell migration,”
Journal of Biological Chemistry, vol. 279, no. 53, pp. 55818–
55826, 2004.
[43] N. Chen and I. Greenwald, “The lateral signal for LIN-
12/Notch in C. elegans vulval development comprises redun-
dant secreted and transmembrane DSL proteins,” Develop-
mental Cell, vol. 6, no. 2, pp. 183–192, 2004.Genetics Research International 9
[44] Q. D. Hu, B. T. Ang, M. Karsak et al., “F3/contactin acts as a
functional ligand for notch during oligodendrocyte matura-
tion,” Cell, vol. 115, no. 2, pp. 163–175, 2003.
[45] X. Y. Cui, Q. D. Hu, M. Tekaya et al., “NB-3/Notch1 pathway
via Deltex1 promotes neural progenitor cell diﬀerentiation
into oligodendrocytes,” Journal of Biological Chemistry, vol.
279, no. 24, pp. 25858–25865, 2004.
[46] M. Eiraku, A. Tohgo, K. Ono et al., “DNER acts as a neuron-
speciﬁc Notch ligand during Bergmann glial development,”
Nature Neuroscience, vol. 8, no. 7, pp. 873–880, 2005.
[47] W. R. Gordon, D. Vardar-Ulu, G. Histen, C. Sanchez-Irizarry,
J. C. Aster, and S. C. Blacklow, “Structural basis for autoinhi-
bition of Notch,” Nature Structural and Molecular Biology, vol.
14, no. 4, pp. 295–300, 2007.
[ 4 8 ] A .L .P a r k s ,K .M .K l u e g ,J .R .S t o u t ,a n dM .A .T .M u s k a v i t c h ,
“Ligand endocytosis drives receptor dissociation and activa-
tion in the Notch pathway,” Development, vol. 127, no. 7, pp.
1373–1385, 2000.
[ 4 9 ]C .B r o u ,F .L o g e a t ,N .G u p t ae ta l . ,“ An o v e lp r o t e o l y t i cc l e a v -
age involved in Notch signaling: the role of the disintegrin-
metalloprotease TACE,” Molecular Cell, vol. 5, no. 2, pp. 207–
216, 2000.
[50] R. Le Borgne and F. Schweisguth, “Notch signaling: endocyto-
sis makes Delta signal better,” Current Biology, vol. 13, no. 7,
pp. R273–R275, 2003.
[51] J. S. Mumm, E. H. Schroeter, M. T. Saxena et al., “A ligand-
induced extracellular cleavage regulates γ-secretase-like prote-
olytic activation of Notch1,” Molecular Cell,v o l .5 ,n o .2 ,p p .
197–206, 2000.
[52] T. Honjo, “The shortest path from the surface to the nucleus:
RBP-Jκ/Su(H) transcription factor,” Genes to Cells, vol. 1, no.
1, pp. 1–9, 1996.
[53] T. Borggrefe and F. Oswald, “The Notch signaling pathway:
transcriptional regulation at Notch target genes,” Cellular and
Molecular Life Sciences, vol. 66, no. 10, pp. 1631–1646, 2009.
[54] S. Bray and M. Furriols, “Notch pathway: making sense of
suppressor of hairless,” Current Biology,v o l .1 1 ,n o .6 ,p p .
R217–R221, 2001.
[55] O. Y. Lubman, S. V. Korolev, and R. Kopan, “Anchoring Notch
genetics and biochemistry: structural analysis of the ankyrin
domain sheds light on existing data,” Molecular Cell, vol. 13,
no. 5, pp. 619–626, 2004.
[56] R. A. Kovall, “More complicated than it looks: assembly of
Notch pathway transcription complexes,” Oncogene, vol. 27,
no. 38, pp. 5099–5109, 2008.
[57] T. Iso, L. Kedes, and Y. Hamamori, “HES and HERP families:
multiple eﬀectors of the Notch signaling pathway,” Journal of
Cellular Physiology, vol. 194, no. 3, pp. 237–255, 2003.
[58] A. Fischer and M. Gessler, “Delta-Notch-and then? Protein
interactions and proposed modes of repression by Hes and
Hey bHLH factors,” Nucleic Acids Research, vol. 35, no. 14, pp.
4583–4596, 2007.
[59] R. Kageyama and T. Ohtsuka, “The Notch-Hes pathway in
mammalian neural development,” Cell Research, vol. 9, no. 3,
pp. 179–188, 1999.
[ 6 0 ]S .K a w a m a t a ,C .D u ,K .L i ,a n dC .L a v a u ,“ O v e r e x p r e s s i o n
of the Notch target genes Hes in vivo induces lymphoid and
myeloid alterations,” Oncogene, vol. 21, no. 24, pp. 3855–3863,
2002.
[ 6 1 ]M .L .D e f t o s ,E .H u a n g ,E .W .O j a l a ,K .A .F o r b u s h ,a n dM .
J. Bevan, “Notch1 signaling promotes the maturation of CD4
and CD8 SP thymocytes,” Immunity, vol. 13, no. 1, pp. 73–84,
2000.
[62] B. Reizis and P. Leder, “Direct induction of T lymphocyte-
speciﬁc gene expression by the mammalian notch signaling
pathway,” Genes and Development, vol. 16, no. 3, pp. 295–300,
2002.
[63] D. Amsen, A. Antov, D. Jankovic et al., “Direct regulation
of Gata3 expression determines the T Helper diﬀerentiation
potential of Notch,” Immunity, vol. 27, no. 1, pp. 89–99, 2007.
[64] D. J. Izon, J. C. Aster, Y. He et al., “Deltex1 redirects lymphoid
progenitors to the B cell lineage by antagonizing Notch1,”
Immunity, vol. 16, no. 2, pp. 231–243, 2002.
[65] E. Lamar, G. Deblandre, D. Wettstein et al., “Nrarp is a novel
intracellular component of the Notch signaling pathway,”
Genes and Development, vol. 15, no. 15, pp. 1885–1899, 2001.
[66] A. C. Spradling, “Developmental genetics of oogenesis,” in
The Development of Drosophila melanogaster,M .B a t ea n d
A. Martinez Arias, Eds., pp. 1–70, Cold Spring Harbor Cold
Spring Harbor Laboratory Press, 1993.
[67] S. Horne-Badovinac and D. Bilder, “Mass transit: epithelial
morphogenesis in the Drosophila egg chamber,” Developmen-
tal Dynamics, vol. 232, no. 3, pp. 559–574, 2005.
[68] R. Bastock and D. St Johnston, “Drosophila oogenesis,”
Current Biology, vol. 18, no. 23, pp. R1082–R1087, 2008.
[69] J. R. Huynh and D. St Johnston, “The origin of asymmetry:
earlypolarisationoftheDrosophilagermlinecystandoocyte,”
Current Biology, vol. 14, no. 11, pp. R438–R449, 2004.
[70] M. Grammont, “Adherens junction remodeling by the Notch
pathway in Drosophila melanogaster oogenesis,” Journal of Cell
Biology, vol. 177, no. 1, pp. 139–150, 2007.
[ 7 1 ]X .W u ,P .S .T a n w a r ,a n dL .A .R a f t e r y ,“ D r o s o p h i l af o l l i c l e
cells: morphogenesis in an eggshell,” Seminars in Cell and
Developmental Biology, vol. 19, no. 3, pp. 271–282, 2008.
[72] E. J. Ward, H. R. Shcherbata, S. H. Reynolds, K. A. Fischer, S.
D. Hatﬁeld, and H. Ruohola-Baker, “Stem cells signal to the
Niche through the Notch pathway in the Drosophila Ovary,”
Current Biology, vol. 16, no. 23, pp. 2352–2358, 2006.
[73] X. Song, G. B. Call, D. Kirilly, and T. Xie, “Notch signaling
controls germline stem cell niche formation in the Drosophila
ovary,” Development, vol. 134, no. 6, pp. 1071–1080, 2007.
[74] S.KluszaandW.M.Deng,“Atthecrossroadsofdiﬀerentiation
and proliferation: precise control of cell-cycle changes by
multiple signaling pathways in Drosophila follicle cells,”
BioEssays, vol. 33, no. 2, pp. 124–134, 2011.
[75] C. Vachias, J. L. Couderc, and M. Grammont, “A two-step
Notch-dependant mechanism controls the selection of the
polarcellpairinDrosophilaoogenesis,”Development,vol.137,
no. 16, pp. 2703–2711, 2010.
[76] S. Roth, “Drosophila oogenesis: coordinating germ line and
soma,” Current Biology, vol. 11, no. 19, pp. R779–R781, 2001.
[77] M. Grammont and K. D. Irvine, “Fringe and Notch specify
polarcellfateduringDrosophilaoogenesis,”Development,vol.
128, no. 12, pp. 2243–2253, 2001.
[78] L. F. Shyu, J. Sun, H. M. Chung, Y. C. Huang, and W. M.
Deng, “Notch signaling and developmental cell-cycle arrest in
Drosophila polar follicle cells,” Molecular Biology of the Cell,
vol. 20, no. 24, pp. 5064–5073, 2009.
[79] E. Assa-Kunik, I. L. Torres, E. D. Schejter, D. St Johnston, and
B. Z. Shilo, “Drosophila follicle cells are patterned by multiple
levels of Notch signaling and antagonism between the Notch
and JAK/STAT pathways,” Development, vol. 134, no. 6, pp.
1161–1169, 2007.
[80] T. Nystul and A. Spradling, “Regulation of epithelial stem cell
replacement and follicle formation in the drosophila ovary,”
Genetics, vol. 184, no. 2, pp. 503–515, 2010.10 Genetics Research International
[81] I. S. Torres, H. L´ opez-Schier, and D. S. Johnston, “A
notch/delta-dependent relay mechanism establishes anterior-
posterior polarity in Drosophila,” Developmental Cell, vol. 5,
no. 4, pp. 547–558, 2003.
[82] H. L´ opez-Schier and D. S. Johnston, “Delta signaling from the
germ line controls the proliferation and diﬀerentiation of the
somatic follicle cells during Drosophila oogenesis,” Genes and
Development, vol. 15, no. 11, pp. 1393–1405, 2001.
[83] W. M. Deng, C. Althauser, and H. Ruohola-Baker, “Notch-
Delta signaling induces a transition from mitotic cell cycle to
endocycle in Drosophila follicle cells,” Development, vol. 128,
no. 23, pp. 4737–4746, 2001.
[84] L. Dobens, A. Jaeger, J. S. Peterson, and L. A. Raftery,
“Bunched sets a boundary for Notch signaling to pattern
anterior eggshell structures during Drosophila oogenesis,”
Developmental Biology, vol. 287, no. 2, pp. 425–437, 2005.
[85] E. Domanitskaya and T. Sch¨ upbach, “CoREST acts as a
positive regulator of Notch signaling in the follicle cells of
Drosophila melanogaster,” Journal of Cell Science, vol. 125, no.
2, pp. 399–341, 2012.
[86] J. Sun, L. Smith, A. Armento, and W. M. Deng, “Regulation
of the endocycle/gene ampliﬁcation switch by Notch and
ecdysone signaling,” Journal of Cell Biology, vol. 182, no. 5, pp.
885–896, 2008.
[87] X. Wang, J. C. Adam, and D. Montell, “Spatially localized
Kuzbanian required for speciﬁc activation of Notch during
border cell migration,” Developmental Biology, vol. 301, no. 2,
pp. 532–540, 2007.
[88] M. Prasad and D. J. Montell, “Cellular and molecular mecha-
nisms of border cell migration analyzed using time-lapse live-
cell imaging,” Developmental Cell, vol. 12, no. 6, pp. 997–1005,
2007.
[89] B. Levine, M. Jean-Francois, F. Bernardi, G. Gargiulo, and
L. Dobens, “Notch signaling links interactions between the
C/EBP homolog slow border cells and the GILZ homolog
bunched during cell migration,” Developmental Biology, vol.
305, no. 1, pp. 217–231, 2007.
[90] L. L. Dobens and L. A. Raftery, “Integration of epithelial
patterning and morphogenesis in Drosophila ovarian follicle
cells,” Developmental Dynamics, vol. 218, pp. 80–93, 2000.
[91] C. A. Berg, “The Drosophila shell game: patterning genes and
morphological change,” Trends in Genetics,v o l .2 1 ,n o .6 ,p p .
346–355, 2005.
[92] E. J. Ward, X. Zhou, L. M. Riddiford, C. A. Berg, and H.
Ruohola-Baker,“BorderofNotchactivityestablishesabound-
ary between the two dorsal appendage tube cell types,”
Developmental Biology, vol. 297, no. 2, pp. 461–470, 2006.
[93] M. J. Boyle and C. A. Berg, “Control in time and space:
tramtrack69 cooperates with notch and ecdysone to repress
ectopic fate and shape changes during Drosophila egg cham-
bermaturation,”Development,vol.136,no.24,pp.4187–4197,
2009.
[94] J. Johnson, T. Espinoza, R. W. McGaughey, A. Rawls, and
J. Wilson-Rawls, “Notch pathway genes are expressed in
mammalian ovarian follicles,” Mechanisms of Development,
vol. 109, no. 2, pp. 355–361, 2001.
[95] D. J. Trombly, T. K. Woodruﬀ, and K. E. Mayo, “Suppression
of notch signaling in the neonatal mouse ovary decreases
primordial follicle formation,” Endocrinology, vol. 150, no. 2,
pp. 1014–1024, 2009.
[96] C. P. Zhang, J. L. Yang, J. Zhang et al., “Notch signaling
is involved in ovarian follicle development by regulating
granulosacellproliferation,”Endocrinology,vol.152,no.6,pp.
2437–2447, 2011.
[97] A. Haapasalo and D. M. Kovacs, “The many substrates of
presenilin/γ-secretase,” Journal of Alzheimer’s Disease, vol. 25,
no. 1, pp. 3–28, 2011.